COM:EDITASMEDICINE
Editas Medicine
- Stock
market
STOCKSindustry
Biotechnologywebsite
editasmedicine.comcrunchbase
editas-medicineipo date
Feb 03, 2016
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. ...Show More